真菌发酵生产鱼油特征脂肪酸

DHA和EPA是鱼油的特征脂肪酸,具有调整血脂、改善大脑功能和维持正常视力等重要作用.一直以来,其来源主要是海产鱼油.近年研究发现许多微生物的脂质中也含有DHA和EPA,特别是一些低等真菌含量甚为丰富,利用其发酵生产DHA和EPA替代鱼油资源具有广阔的前景.阐述了能产生EPA,DHA的真菌及其合成途径和发酵影响因素.     

生物法转化甘油生产1,3-二羟基丙酮的研究进展

1,3-二羟基丙酮(DHA)是一种重要的化工医药中间体,广泛应用于化妆品、医药和食品等领域,开展提高DHA生产效能的研究对于工业生产具有指导意义。甘油生物转化生产DHA是目前主要的工业生产方法,但存在菌株转化效能有待提高、底物和产物抑制、溶氧限制等问题。本文概述了DHA的生物合成途径、菌株改良策略、生产工艺及分离提取等方面的研究进展,指出利用代谢工程技术改造菌种、优化生产工艺、简化分离提纯方法是今后的研究方向。     

DHA在肺癌防治中的研究进展

二十二碳六烯酸(docosahexaenoic acid, DHA)是人体必需多不饱和脂肪酸omega-3 (n-3 polyunsaturated fatty acid, n-3 PUFA)中的重要成员。流行病学调查显示深海鱼油中丰富的DHA具有广泛的抗炎和抗肿瘤作用,特别是在肺癌中,DHA还作为潜在的抗癌营养素参与患者的营养干预治疗。为了全面了解DHA在肺癌中的抗肿瘤作用,该文拟从DHA在肺癌预防及治疗中的人群研究、DHA在肺癌中的抗肿瘤作用机制和DHA的联合治疗等三方面进行综述。     

饲料中DHA含量对中华绒螯蟹幼蟹生长、脂类组成和低氧胁迫的影响

二十二碳六烯酸（C22:6n-3,DHA）对甲壳动物生长、蜕壳、性腺发育、免疫保护和抗环境胁迫具有重要的调节作用,探讨饲料中脂肪酸营养与中华绒螯蟹幼蟹生长和耐低氧胁迫的调控关系具有重要的理论意义和现实意义。通过单个体养殖试验、生化分析、低氧胁迫及生理指标测定等方法,研究了饲料中DHA含量对中华绒螯蟹幼蟹（初始均重为0.6g左右）成活、生长、脂类组成和低氧胁迫下生理指标的影响,探讨幼蟹饲料中适宜的DHA含量。结果表明:（1）饲料中DHA含量对中华绒螯蟹幼蟹的成活、生长、蜕壳和肝胰腺指数无显著影响;（2）饲料中DHA含量对幼蟹肝胰腺水分、肌肉水分及总脂含量均无显著影响,但饲料中过量DHA（0.81%）导致幼蟹肝胰腺总脂含量显著升高;（3）幼蟹肝胰腺和肌肉中的DHA均随着饲料中DHA含量升高而显著上升,但DHA相对保留率（组织中DHA与饲料中DHA的比值）随着饲料中DHA含量上升而显著下降,整体上肌肉中各PUFA的相对保留率远高于肝胰腺。无论饲料中DHA/EPA比值如何变化,肌肉中DHA/EPA均小于1,这说明幼蟹肌肉需要更多的EPA;（4）饲料中添加适量的DHA（0.18%0.28%）可以提高低氧胁迫下幼蟹血淋巴中超氧化物歧化酶的活性,降低其乳酸和丙二醛含量,从而提高幼蟹的抗低氧胁迫能力。综上,中华绒螯蟹幼蟹饲料中适宜DHA含量为0.2%左右。       

一株具有工业化生产DHA前景的破囊壶菌

多不饱和脂肪酸是保持人体健康不可缺少的营养成分之一,尤其是二十二碳六烯酸(DHA)作为细胞膜磷脂的重要组分,具有非常重要的医药应用和营养价值。目前,在食品工业中,DHA已经添加至牛奶或奶粉中,用作功能性营养强化剂。20世纪80年代,DHA的唯一来源是鱼油,但鱼油的腥味、重金属污染等问题,促使人们探索生产DHA的其他途径如微生物发酵。诱变和筛选是微生物选育过程中比较重要的手段,可以快速使菌株朝着人类所需要的方向突变。UV诱变和化学药物胁迫筛选是使野生株定向突变的一种很好的办法。目前国内外研究主要针对裂殖壶菌属菌株进行诱变育种,许永利[1]用紫外线诱变和喹禾灵筛选方法对裂殖壶菌(Schizochytrium limacinu)进行诱变选育,突变菌株生物量和DHA含量比对照菌株均有提高。吴克刚等[2]利用添加植物激素对Thraustochytriu roseum MF2进行培育诱变,从而获得更高的DHA量,但在脂质含量和DHA在脂质占比率上都不存在明显变化。本期介绍梁园梅、成家杨等[3]发表的论文《高产DHA破囊壶菌Aurantiochytrium sp.PKU#SW7诱变株的筛选》,作者采用紫外线和药物双重诱变胁迫破囊壶菌获得一株突变株,其在生物量、脂质含量和DHA在脂质占比率上都有显著性提高,相比前人的研究,作者获得的突变株有显著优越性,且突变株DHA生产能力传代4次后仍然保持稳定,具有较高的工业价值。在后续的研究中作者若能对筛选条件、培养基(如利用廉价碳源)和培养条件等方面实行进一步优化,提高突变株生物量,降低突变株发酵生产DHA生产成本,将能获得更高的商业价值。     

诱变育种在产油微生物生产DHA中的研究进展

二十二碳六烯酸(DHA)对维持人体正常的生理功能至关重要,具有极高的生物医学价值。产油微生物是指具有很强的脂肪酸合成能力,DHA占总脂肪酸含量相对较高的一类微生物,是获取DHA的新途径。诱变育种作为一种有效的变异手段在产油微生物选育与改良中显示了极为重要的作用和十分诱人的前景。综述了通过物理和化学诱变选育高产DHA菌株的机理及方法,其中物理诱变包括γ射线、紫外线、离子束和常压室温等离子体等;化学诱变包括甲基磺酸乙酯、亚硝基胍和硫酸二乙酯等;主要介绍了不同诱变育种方式在产油微生物生产DHA研究方面取得的成就,探讨了诱变育种的发展方向,提出了不同诱变育种方式相结合的复合育种的思路,以期对今后产油微生物生产DHA的研究有所启发。     

EPA DHA对体内脂质代谢影响的研究进展

EPA和DHA是人体所需的重要的不饱和脂肪酸,发挥多种重要的生理作用,影响人类的生长发育与身体健康。近年来,人们的健康保健意识逐渐加强,更为关注EPA和DHA的保健营养价值。因此,EPA和DHA生物制品的提取开发成为了食物资源开发利用的热点问题。作为有较疗效好、安全性高的营养品,培养富含EPA、DHA的生物制品会有一个光明的前景。本文介绍了EPA和DHA的生物学特性、来源,并着重阐述其在机体脂质代谢中的作用。     

影响真菌发酵过程中多不饱和脂肪酸积累的条件

多不饱和脂肪酸（Polyunsaturatedfattyacid,PUFA）中的大多数都是生物活性物质的前体,具有抗氧化、抗衰老等作用[13]。如γ-亚麻酸（GLA）是合成前列腺素的前体,人体内缺乏GLA就会引起生理不调、血脂升高、动脉硬化、糖尿病以至癌症等疾病[8,9,15]。二十二碳六烯酸（DHA）和二十碳五烯酸（EPA）等ω－3脂肪酸具有健脑、防治心血管疾病、风湿性关节炎、视力下降、癌症和心脏摔死等作用。尤其是DHA和EPA可以促进胎儿脑细胞发育,婴儿脑细胞生长,促进青少年提高记忆力,防治老年性痴呆,有“脑黄金”之美称。天然的DHA和EPA…     

利用海洋微藻生产富含DHA的单细胞油脂

DHA是神经组织的基本组分,人体合成DHA的能力有限,从饮食中摄取足够的DHA十分重要。特别是婴幼儿缺乏DHA会影响智力、视力和生理发育。鱼油是目前DHA的最普遍来源,但是鱼油的产量和质量难以满足人们的需要。利用生物技术生产DHA是发展方向,研究得最多的是用海洋真菌和藻类生产DHA,其中用海洋藻类Crypthecodiniumcohnii生产富含DHA的单细胞油脂已达工业化规模,而且产品的稳定性,纯度,安全性和生物利用率都优于鱼油,目前已应用于婴儿奶粉和作为辅助食品。     

四个脂肪酸合成酶基因在哺乳动物细胞中的超表达提高长链多不饱和脂肪酸生物合成效率

DHA(22:6n-3)、EPA(20:5n-3)和ARA(20:4n-6)三种长链多不饱和脂肪酸在生物体内活性最强,它们在促进大脑发育和功能维持以及在预防和治疗心血管疾病、炎症、癌症等多种疾病方面有着重要作用。然而,尽管哺乳动物体内有完整的长链多不饱和脂肪酸合成酶系,但哺乳动物合成这些长链多不饱和脂肪酸的效率很低而主要依赖于食物获取。本研究应用转基因方法,将哺乳动物来源的Δ6和Δ5脂肪酸去饱和酶以及Δ6和Δ5脂肪酸延长酶这4种酶的编码基因构建成为一个多基因表达载体,然后转染哺乳动物细胞HEK293T,实现了4个目的基因的超表达,再通过气质联用(GC-MS)分析证实了DHA、EPA和ARA等长链多不饱和脂肪酸的合成效率及水平显著增加,DHA的水平更是提高了2.5倍。由此可见,哺乳动物具有某种抑制长链多不饱和脂肪酸高水平合成的机制,但通过Δ6和Δ5脂肪酸去饱和酶以及Δ6和Δ5脂肪酸延长酶的超表达,能够打破哺乳动物这种抑制机制,从而显著提高DHA、EPA、ARA等的合成水平。同时,本研究的思路也为在转基因动物中生产长链多不饱和脂肪酸提供了重要的启示。     

外源添加剂促进裂殖壶菌合成DHA

为提高二十二碳六烯酸（DHA）产量,根据裂殖壶菌生物合成DHA的代谢途径,考察外源添加剂对裂殖壶菌发酵生产DHA影响。研究表明：分生物素、柠檬酸、苹果酸和洛伐他汀均能提高裂殖壶菌DHA的合成能力。同时添加生物素、苹果酸和洛伐他汀时能够显著提高DHA的产量,DHA的最高产量达到11.55 g/L,相比对照提高71.87%。     

DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity

Patients and models of cystic fibrosis (CF) exhibit consistent abnormalities of polyunsaturated fatty acid composition, including decreased linoleate (LA) and docosahexaenoate (DHA) and variably increased arachidonate (AA), related in part to increased expression and activity of fatty acid desaturases. These abnormalities and the consequent CF-related pathologic manifestations can be reversed in CF mouse models by dietary supplementation with DHA. However, the mechanism is unknown. This study investigates this mechanism by measuring the effect of exogenous DHA and eicosapentaenoate (EPA) supplementation on fatty acid composition and metabolism, as well as on metabolic enzyme expression, in a cell culture model of CF. We found that both DHA and EPA suppress the expression and activity of Δ5- and Δ6-desaturases, leading to decreased flux through the n-3 and n-6 PUFA metabolic pathways and decreased production of AA. The findings also uncover other metabolic abnormalities, including increased fatty acid uptake and markedly increased retroconversion of DHA to EPA, in CF cells. These results indicate that the fatty acid abnormalities of CF are related to intrinsic alterations of PUFA metabolism and that they may be reversed by supplementation with DHA and EPA.     

Regulation of docosahexaenoic acid production by Schizochytrium sp.: effect of nitrogen addition

Docosahexaenoic acid (DHA) percentage in total fatty acids (TFAs) is an important index in DHA microbial production. In this study, the change of DHA percentage in response to fermentation stages and the strategies to increase DHA percentage were investigated. Two kinds of conventional nitrogen sources, monosodium glutamate (MSG) and ammonium sulfate (AS), were tested to regulate DHA synthesis. Results showed that MSG addition could accelerate the substrate consumption rate but inhibit lipid accumulation, while AS addition could increase DHA percentage in TFAs effectively but extend fermentation period slightly. Finally, the AS addition strategy was successfully applied in 7,000-L fermentor and DHA percentage in TFAs and DHA yield reached 46.06 % and 18.48 g/L, which was 19.54 and 17.41 % higher than that of no-addition strategy. This would provide guidance for the large-scale production of the other similar polyunsaturated fatty acid, and give insight into the nitrogen metabolism in oil-producing microorganisms.     

Optimization of docosahexaenoic acid production by Schizochytrium limacinum SR21

Culture conditions of Schizochytrium limacinum SR21 for the purpose of microbial docosahexaenoic acid (DHA) production were investigated. The strain SR21 showed a wide tolerance to salinity; that is, the optimum salinity was between 50% and 200% that of sea water. Monosaccharides (glucose and fructose) and glycerol supported good cell growth and DHA yield. Di- and polysaccharides, oleic acid, and linseed oil gave low DHA yields. A high content of DHA (more than 30% of total fatty acids) was obtained from culture on glucose, fructose, and glycerol, and also the strain had simple polyunsaturated fatty acid profiles. The major polyunsaturated fatty acids other than DHA were n-6 docosapentaenoic acid only, and the contents of icosapentaenoic acid and arachidonic acid were less than 1%. Using corn steep liquor as a nitrogen source, a high total fatty acid content was obtained. The total fatty acid content in the dry cell weight increased as the concentration of the nitrogen source decreased, reached more than 50%. An increase in carbon source concentration led to a high DHA yield. A maximum DHA yield of more than 4 g/l was obtained in both glucose and glycerol media at 9% and 12% respectively. S. limacinum SR21 was thought to be a promising resource for microbial DHA production yielding a good level of productivity as well as a simple polyunsaturated fatty acid profile. Received: 26 June 1997 / Received revision: 29 August 1997  / Accepted: 19 September 1997     

Growth condition optimization for docosahexaenoic acid (DHA) production by Moritella marina MP-1

The marine organism Moritella marina MP-1 produces the polyunsaturated fatty acid docosahexaenoic acid (DHA). While the basic metabolic pathway for DHA production in this organism has been identified, the impact of growth conditions on DHA production is largely unknown. This study examines the effect of supplemental carbon, nitrogen and salts, growth temperature and media composition and pH on DHA and biomass production and the fatty acid profile. The addition of supplemental nitrogen significantly increased the overall DHA titer via an increase in biomass production. Supplemental glucose or glycerol increased biomass production, but decreased the amount of DHA per biomass, resulting in no net change in the DHA titer. Acidification of the baseline media pH to 6.0 increased DHA per biomass. Changes in growth temperature or provision of supplemental sodium or magnesium chloride did not increase DHA titer. This organism was also shown to grow on defined minimal media. For both media types, glycerol enabled more DHA production per biomass than glucose. Combination of these growth findings into marine broth supplemented with glycerol, yeast extract, and tryptone at pH?6.0 resulted in a final titer of 82?±?5 mg/L, a nearly eightfold increase relative to the titer of 11?±?1 mg/L seen in the unsupplemented marine broth. The relative distribution of other fatty acids was relatively robust to growth condition, but the presence of glycerol resulted in a significant increase in myristic acid (C14:0) and decrease in palmitic acid (C16:0). In summary, DHA production by M. marina MP-1 can be increased more than fivefold by changing the growth media. Metabolic engineering of this organism to increase the amount of DHA produced per biomass could result in additional increases in titer.     

利用环境胁迫提高破囊壶菌二十二碳六烯酸生产的研究进展

破囊壶菌由于具备生产多种高值天然活性物质的能力，如二十碳五烯酸(eicosapentaenoic acid, EPA)、二十二碳六烯酸(docosahexaenoic acid, DHA)、角鲨烯和类胡萝卜素等，目前已被视为商业脂质生产的优质来源。本文首先对破囊壶菌的生态作用和生物技术价值进行介绍，并概述了脂肪酸的两条生物合成途径；其次重点阐述了NaCl、温度、溶氧和pH这4种环境胁迫因子对破囊壶菌生长、脂质积累、脂肪酸组成和DHA生产的影响；随后总结了当前利用环境胁迫因子的渗透调节策略、分段发酵策略和缓解氧化应激策略提升破囊壶菌DHA生物合成能力的研究现状；最后指出了破囊壶菌在环境胁迫的分子调控机制、分段式发酵策略、菌株进化及代谢工程等方面存在的问题，并对如何改进这些问题以及未来可能的发展方向进行了展望。该综述旨在为破囊壶菌实现高效工业化生产DHA提供有效的参考。     

Omega-3 biotechnology: Thraustochytrids as a novel source of omega-3 oils

Thraustochytrids are large-celled marine heterokonts and classified as oleaginous microorganisms due to their production of docosahexaenoic (DHA) and eicosapentaenoic (EPA) ω-3-fatty acids. The applications of microbial DHA and EPA for human health are rapidly expanding, and a large number of clinical trials have been carried out to verify their efficacy. The development of refined isolation and identification techniques is important for the cultivation of thraustochytrids. With a high proportion of lipid biomass, thraustochytrids are also amenable to various production strategies which increase omega-3 oil output. Modifications to the existing lipid extraction methods and utilisation of sophisticated analytical instruments have increased extraction yields of DHA and EPA. Other metabolites such as enzymes, carotenoids and extracellular polysaccharides can also be obtained from these marine protists. Approaches such as the exploration for more diverse isolates having fast growth rates, metabolic engineering including gene cloning, and growing thraustochytrids on alternate low cost carbon source, will further enhance the biotechnological potential of thraustochytrids.     

Effects of organic and inorganic salts on docosahexaenoic acid (DHA) production by a locally isolated strain of Thraustochytrium sp. T01

Abstract

The traditional source for docosahexaenoic acid (DHA) i.e. fish oil is currently being replaced by microbial sources due to the unpleasant odor and the risk of chemical contamination of fish. Thraustochytrium sp., marine microalgae-like protist is a known source of DHA. In our previous study, we reported a high yielding strain, T01, of Thraustochytrium sp. for DHA production isolated from the mangroves of South India. This strain shows promising yields of biomass and DHA. Shake flask study of T01 yielded 6.17?±?0.04 gL^?1 of DHA. In the present work, we report the effects of organic and inorganic salts on DHA production. Addition of organic salts such as sodium acetate, pyruvate, citrate and malate led to increase in the DHA content in T01 strain. The DHA content increased by 40–46% on addition of sodium salts of organic acids, while inorganic phosphates increased DHA by 33%. The total lipid content also increased (28–33%) with salts of organic acids and 28% with phosphate, but not as much as the increase in DHA. Addition of all the salts together did not show a significant increase in lipid and DHA contents as compared to the addition of individual salts.     

真菌发酵生产EPA及DHA影响因素的研究进展

对真菌发酵生产EPA及DHA的影响因素进行综述 ,介绍了菌种、碳源、氮源、C/N比、pH值、温度、发酵时间、通气量、代谢途径的调控、种龄和接种量等因素对EPA及DHA产量的影响。     

A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA

Specific fatty acid alterations have been described in the blood and tissues of cystic fibrosis (CF) patients. The principal alterations include decreased levels of linoleic acid (LA) and docosahexaenoic acid (DHA). We investigated the potential mechanisms of these alterations by studying the cellular uptake of LA and DHA, their distribution among lipid classes, and the metabolism of LA in a human bronchial epithelial cell model of CF. CF (antisense) cells demonstrated decreased levels of LA and DHA compared with wild type (WT, sense) cells expressing normal CFTR. Cellular uptake of LA and DHA was higher in CF cells compared with WT cells at 1 h and 4 h. Subsequent incorporation of LA and DHA into most lipid classes and individual phospholipids was also increased in CF cells. The metabolic conversion of LA to n-6 metabolites, including 18:3n-6 and arachidonic acid, was upregulated in CF cells, indicating increased flux through the n-6 pathway. Supplementing CF cells with DHA inhibited the production of LA metabolites and corrected the n-6 fatty acid defect. In conclusion, the evidence suggests that low LA level in cultured CF cells is due to its increased metabolism, and this increased LA metabolism is corrected by DHA supplementation.